Genexine Inc. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
5,755
16,656
32,520
11,352
28,455
Cost of Goods Sold (COGS) incl. D&A
6,400
9,889
8,440
5,615
11,412
Gross Income
645
6,767
24,079
5,737
17,043
SG&A Expense
6,249
10,563
18,166
36,000
43,761
EBIT
7,051
5,208
1,087
-
26,859
Unusual Expense
1,043
125
1,238
11
548
Non Operating Income/Expense
1,043
879
2,366
622
12,219
Interest Expense
1,948
1,031
290
736
1,106
Pretax Income
8,787
5,233
4,802
30,933
19,330
Equity in Affiliates
212
2,181
6,229
-
-
Consolidated Net Income
8,999
7,413
1,427
30,933
19,330
Net Income
8,999
7,413
1,427
30,933
19,330
Net Income After Extraordinaries
8,999
7,413
1,427
30,933
19,330
Net Income Available to Common
8,999
7,413
1,427
30,933
19,330
EPS (Basic)
721.00
447.59
85.20
1,921.00
1,051.00
Basic Shares Outstanding
12
17
17
16
18
EPS (Diluted)
721.06
447.59
85.20
1,920.53
1,050.51
Diluted Shares Outstanding
12
17
17
16
18
EBITDA
2,615
1,354
4,693
28,338
24,209
Other Operating Expense
157
1,411
4,827
622
141
Non-Operating Interest Income
212
251
401
584
221
Equity in Affiliates (Pretax)
-
-
-
930
3,066
About Genexine
View Profile
